RushNet Past Earnings Performance
Past criteria checks 0/6
RushNet's earnings have been declining at an average annual rate of -506.4%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been growing at an average rate of 17% per year.
Key information
-506.4%
Earnings growth rate
-570.6%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 17.0% |
Return on equity | -160.0% |
Net Margin | -9.6% |
Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How RushNet makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 22 | 7 | -1 | 6 | 0 |
30 Jun 22 | 6 | -1 | 4 | 0 |
31 Mar 22 | 6 | 0 | 4 | 0 |
31 Dec 21 | 6 | 0 | 3 | 0 |
31 Dec 20 | 4 | 1 | 2 | 0 |
Quality Earnings: RSHN is currently unprofitable.
Growing Profit Margin: RSHN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if RSHN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare RSHN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RSHN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.2%).
Return on Equity
High ROE: RSHN has a negative Return on Equity (-160.05%), as it is currently unprofitable.